Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Engineering × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Specimen Handling 42 Magnetic Resonance Spectroscopy 32 Carboplatin 31 Cyclophosphamide 29 Paclitaxel 27 Cisplatin 27 pembrolizumab 25 Oxaliplatin 24 Gemcitabine 24 Drug Therapy 22 Biopsy 22 Capecitabine 21 Bevacizumab 20 Docetaxel 19 Standard of Care 18 Radiotherapy 18 Fluorouracil 18 venetoclax 17 Nivolumab 17 tislelizumab 16 Injections 16 toripalimab 15 fludarabine 15 Azacitidine 15 Leucovorin 13 Dexamethasone 13 cemiplimab 12 Pemetrexed 12 Irinotecan 12 Cytarabine 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡